Nuclear Medicine and Molecular Imaging, published by SPRINGER HEIDELBERG, stands as a pivotal platform in the interdisciplinary field of radiology and nuclear medicine, focusing on innovative research and developments from 2010 to 2024. With its ISSN 1869-3474 and E-ISSN 1869-3482, this journal aims to disseminate advanced studies that explore the diagnostic and therapeutic applications of nuclear medicine technologies. Operating from Germany, it has positioned itself in the Q3 category within the Radiology, Nuclear Medicine and Imaging sector, showcasing its relevance among peer journals, with a Scopus rank of #204 out of 333. This journal not only serves as an essential resource for researchers and practitioners eager to stay abreast of modern methodologies and findings but also underscores the crucial advancements in molecular imaging techniques. Although currently not an open-access journal, it doesn't detract from its mission to promote knowledge exchange among academia and the medical community, thus paving the way for innovative solutions and improved patient care in nuclear medicine.

NUKLEARMEDIZIN-NUCLEAR MEDICINE is a prestigious journal published by Georg Thieme Verlag KG, focusing on pivotal advancements in the fields of Nuclear Medicine, Radiology, and Imaging. Established in 1959, this journal has served as a critical platform for disseminating innovative research, reviews, and clinical guidelines until its anticipated convergence in 2024. With an ISSN of 0029-5566 and an E-ISSN of 2567-6407, NUKLEARMEDIZIN is acknowledged in the academic community as a Q3 category journal within Medicine (miscellaneous) and Radiology, Nuclear Medicine, and Imaging as of 2023, highlighting its ongoing contribution to the interdisciplinary dialogue in healthcare. Although the journal does not currently offer open access, it remains accessible to professionals and students through various academic databases, ensuring that cutting-edge knowledge in this growing field is shared widely. Researchers interested in the latest methods and technologies in Nuclear Medicine will find NUKLEARMEDIZIN a valuable resource for enhancing their work and understanding the complexities of modern imaging modalities.

NUCLEAR MEDICINE AND BIOLOGY, published by Elsevier Science Inc, is a premier journal dedicated to advancing the fields of nuclear medicine and molecular biology. Since its inception in 1986, this journal has served as a vital platform for the dissemination of high-quality research, with a clear focus on the innovative applications of nuclear techniques in biological settings. It is categorized in the Q3 tier for both Cancer Research and Molecular Medicine, and Q2 for Radiology, Nuclear Medicine and Imaging, highlighting its significant standing within these disciplines. The journal's Scopus rankings reflect its strong impact, placing it in the top quartile of its categories, particularly in Radiology, Nuclear Medicine, and Imaging. Researchers, professionals, and students alike will find this an invaluable resource for contemporary research findings and methodologies in nuclear medicine and its biological applications. Access to the journal is provided through subscription, ensuring that quality content remains available to its wide-ranging audience.

ANNALS OF NUCLEAR MEDICINE is a prominent academic journal dedicated to the field of nuclear medicine, published by Springer. With a rich publication history dating back to 1987 and continuing through 2024, this journal serves as a vital resource for researchers and practitioners interested in the latest developments in nuclear imaging, radiopharmaceuticals, and therapeutic applications. Ranked in the second quartile (Q2) for both Medicine (miscellaneous) and Radiology, Nuclear Medicine, and Imaging categories in 2023, it maintains a strong position in the academic community, with an impressive Scopus rank of #104 out of 333 in its field, placing it in the 68th percentile. The journal is not open access but offers a range of access options through institutional or individual subscriptions, ensuring that critical research findings reach a wide audience. By fostering high-quality, peer-reviewed articles, ANNALS OF NUCLEAR MEDICINE plays a crucial role in advancing the understanding and practical application of nuclear medicine techniques, making it an essential journal for professionals and students aiming to stay at the forefront of this evolving discipline.

Imaging, published by AKADEMIAI KIADO ZRT, is an esteemed open-access journal dedicated to the field of medical imaging, established in 2020. With an E-ISSN of 2732-0960 and based in Budapest, Hungary, this journal provides a vital platform for the dissemination of cutting-edge research and advancements in imaging techniques, especially in the realms of radiology, nuclear medicine, and ultrasound technology. While currently positioned in the Q4 category across multiple medical specialties, the journal continues to strive for improvements in visibility and impact, contributing to the evolving discourse in medical imaging. The journal aims to facilitate an inclusive and collaborative environment for researchers, professionals, and students, inviting them to share their findings and insights to enhance the field's development. With open-access availability since its inception, Imaging ensures free and easy access to its content, fostering a greater understanding and appreciation of innovative imaging practices worldwide.

Clinical Imaging, published by Elsevier Science Inc, is a renowned journal dedicated to the field of radiology, nuclear medicine, and imaging. With an ISSN of 0899-7071 and an E-ISSN of 1873-4499, this esteemed publication has established its significance in advancing imaging science since its inception in 1989 and continues to make impactful contributions to the discipline through 2024. The journal holds a prestigious Q2 ranking in the category of Radiology, Nuclear Medicine, and Imaging, reflecting its critical role in bridging research and clinical practice. Currently ranked #113 out of 333 by Scopus, with a notable 66th percentile, it offers a platform for disseminating high-quality research, reviews, and case studies that inspire innovation and enhance imaging techniques. Although it primarily functions as a subscription-based journal, it remains dedicated to accessibility and the dissemination of pivotal findings that inform both academia and clinical settings. Clinical Imaging is essential for researchers, professionals, and students alike, offering insights that shape the future of diagnostic imaging.

Radiologic Clinics of North America, published by W B Saunders Co-Elsevier Inc, stands as a pivotal resource in the field of medical imaging and radiology. With a solid history dating back to 1963 and converging years extending to 2024, this journal has established itself as a reputable platform for original research, comprehensive reviews, and insightful discussions that advance the knowledge and practice of radiology, nuclear medicine, and imaging. Holding a Q2 classification in both the miscellaneous medicine and radiology categories and positioned within the 56th percentile among its peers, its contributions are vital for both academic research and clinical applications. Although it does not offer open access, the journal remains accessible through institutional subscriptions and is a must-read for researchers, healthcare professionals, and students keen on the latest developments in radiological practices. With a dedicated editorial board and a commitment to the highest academic standards, Radiologic Clinics of North America continues to shape the future of the medical imaging field.

JOURNAL OF COMPUTER ASSISTED TOMOGRAPHY, published by Lippincott Williams & Wilkins, stands as a vital resource in the field of Radiology, Nuclear Medicine, and Imaging. Since its inception in 1977, this journal has been dedicated to advancing the understanding and application of computer-assisted tomography, emphasizing innovative research and clinical practices that enhance diagnostic imaging techniques. With an impact factor reflective of its rigorous scholarship and relevance—ranking in the Q3 category—the journal serves as an essential platform for contributors and readers alike, navigating the challenges and opportunities within a rapidly evolving field. Researchers, professionals, and students are encouraged to engage with the rich repository of articles that cover emerging technologies, clinical applications, and theoretical advancements, collectively fostering a deeper comprehension of imaging sciences. Although not currently designated as an open-access journal, it continues to enhance discourse in the community from its headquarters in Philadelphia, PA, maintaining a commitment to the highest standards of academic excellence.

NUCLEAR MEDICINE COMMUNICATIONS is a prestigious academic journal published by Lippincott Williams & Wilkins, focusing on the multifaceted field of nuclear medicine and its applications in diagnostics and therapy. With a solid history spanning from 1980 to 2024, this journal provides a platform for peer-reviewed research articles, clinical studies, and innovative techniques that enrich the knowledge base within the fields of {{medicinal applications, patient care, and imaging technology}}. Currently classified in the Q3 quartile for both Medicine (Miscellaneous) and Radiology, Nuclear Medicine, and Imaging, the journal reflects its commitment to advancing healthcare practices. Although it does not offer open access options, its accessibility through reputable institutions promotes scholarly exchange among researchers, professionals, and students alike. The critical insights provided in NUCLEAR MEDICINE COMMUNICATIONS are essential for those dedicated to enhancing patient outcomes through cutting-edge nuclear medical technologies.

The American Journal of Nuclear Medicine and Molecular Imaging (ISSN: 2160-8407), published by E-CENTURY PUBLISHING CORP, is a distinguished platform for the dissemination of cutting-edge research in the fields of nuclear medicine and molecular imaging. With a commitment to advancing scientific inquiry and clinical applications, this journal serves as a vital resource for researchers, clinicians, and students dedicated to exploring innovative imaging modalities, radiopharmaceuticals, and their applications in diagnosing and treating various medical conditions. Although currently not available as an open-access journal, this publication plays a crucial role in fostering academic dialogue and collaboration within the medical community. Its diverse range of topics and expert contributions underscore its impact in bridging the gap between research findings and clinical practice, making it an essential read for anyone interested in the rapidly evolving landscape of nuclear medicine and imaging technologies.